Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.
Read More…
Industry, Sector and Symbol
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CIKN/A
Phone44 3300 581845
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£136,000.00
Profitability
Miscellaneous
Employees70
Next Earnings DateN/A
OptionableOptionable
Sensyne Health (LON:SENS) Frequently Asked Questions
What is Sensyne Health's stock symbol?
Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."
What price target have analysts set for SENS?
3 Wall Street analysts have issued twelve-month price targets for Sensyne Health's shares. Their predictions range from GBX 260 to GBX 262. On average, they expect Sensyne Health's stock price to reach GBX 261.33 in the next twelve months. This suggests a possible upside of 113.3% from the stock's current price. View Analyst Price Targets for Sensyne Health.
What is the consensus analysts' recommendation for Sensyne Health?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sensyne Health.
Has Sensyne Health been receiving favorable news coverage?
Headlines about SENS stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sensyne Health earned a coverage optimism score of -1.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Sensyne Health.
Who are some of Sensyne Health's key competitors?
Some companies that are related to Sensyne Health include Craneware (CRW), Alcidion Group (ALC), Mach7 Technologies (M7T), Kneat.com (KSI), Reliq Health Technologies (RHT), Medadvisor (MDR), Oneview Healthcare (ONE), CogState (CGS), Induction Healthcare Group (INHC), Vitalhub (VHI), 1ST Group (1ST), ICSGlobal (ICS), Jayex Healthcare (JHL), CardioComm Solutions (EKG) and Diagnos (ADK).
What other stocks do shareholders of Sensyne Health own?
How do I buy shares of Sensyne Health?
Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Sensyne Health's stock price today?
One share of SENS stock can currently be purchased for approximately GBX 122.50.
How big of a company is Sensyne Health?
What is Sensyne Health's official website?
How can I contact Sensyne Health?
The company can be reached via phone at 44 3300 581845.
MarketBeat Community Rating for Sensyne Health (LON SENS)
MarketBeat's community ratings are surveys of what our community members think about Sensyne Health and other stocks. Vote "Outperform" if you believe SENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days.
